文献速递呼吸危重症与机械通气

ARDS亚表型对高PEEP策略的差异反应:贝叶斯分析

Differential Effect of Positive End-Expiratory Pressure Strategies in Patients With ARDS: A Bayesian Analysis of Clinical Subphenotypes.
PubMed 文献 · Chest · 2024-05-18

该研究基于ALVEOLI和ART两项随机试验数据,用9个常规临床变量将1559例ARDS患者分为两种亚表型,并用贝叶斯分层logistic模型评估不同PEEP策略对28天死亡率的影响。结果显示,高PEEP策略在亚表型A患者中可能增加28天死亡率,而在亚表型B患者中未见明显获益或损害。

要点

  • 高PEEP策略在亚表型A中与28天死亡率升高相关,ALVEOLI研究OR 1.61,ART研究OR 1.73。
  • 亚表型B中高PEEP与较低PEEP的28天死亡率无显著差异,OR分别为0.95和1.00。
  • PEEP策略的效应不受PaO2/FiO2、驱动压或疾病严重程度影响。

核心结论

  • ARDS两种亚表型对PEEP策略存在差异反应,高PEEP策略在亚表型A中可能有害。

研究设计与样本

  • 基于ALVEOLI和ART两项比较不同PEEP策略的ARDS试验数据,纳入1559例ARDS患者,用贝叶斯分层logistic模型分析28天死亡率。

主要发现

  • 在ALVEOLI研究中,亚表型A患者接受高PEEP策略的28天死亡率OR为1.61(95% CrI 0.90-2.94),有害概率94.3%。
  • 在ART研究中,亚表型A患者接受高PEEP策略的28天死亡率OR为1.73(95% CrI 1.01-2.98),有害概率97.7%。
  • 在ALVEOLI研究中,亚表型B患者高PEEP策略的28天死亡率OR为0.95(95% CrI 0.51-1.73),获益概率56.4%。
  • 在ART研究中,亚表型B患者高PEEP策略的28天死亡率OR为1.00(95% CrI 0.63-1.55),获益概率50.7%。
  • 上述效应未受PaO2/FiO2比值、驱动压或疾病严重程度影响。

临床怎么用

  • 对ARDS患者可考虑基于亚表型选择PEEP策略,亚表型A患者需谨慎使用高PEEP。
  • 该发现可用于未来临床试验的预测性富集设计。

局限性

  • 研究为对两项既往试验数据的二次分析,亚表型分类基于9个常规临床变量。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: ARDS is a heterogeneous condition with two subphenotypes identified by different methodologies. Our group similarly identified two ARDS subphenotypes using nine routinely available clinical variables. However, whether these are associated with differential response to treatment has yet to be explored. RESEARCH QUESTION: Are there differential responses to positive end-expiratory pressure (PEEP) strategies on 28-day mortality according to subphenotypes in adult patients with ARDS? STUDY DESIGN AND METHODS: We evaluated data from two prior ARDS trials (Higher vs Lower Positive End-Expiratory Pressures in Patients With the ARDS [ALVEOLI] and the Alveolar Recruitment in ARDS Trial [ART]) that compared different PEEP strategies. We classified patients into one of two subphenotypes as described previously. We assessed the differential effect of PEEP with a Bayesian hierarchical logistic model for the primary outcome of 28-day mortality. RESULTS: We analyzed data from 1,559 patients with ARDS. Compared with lower PEEP, a higher PEEP strategy resulted in higher 28-day mortality in patients with subphenotype A disease in the ALVEOLI study (OR, 1.61; 95% credible interval [CrI], 0.90-2.94) and ART (OR, 1.73; 95% CrI, 1.01-2.98), with a probability of harm resulting from higher PEEP in this subphenotype of 94.3% and 97.7% in the ALVEOLI and ART studies, respectively. Higher PEEP was not associated with mortality in patients with subphenotype B disease in each trial (OR, 0.95 [95% CrI, 0.51-1.73] and 1.00 [95% CrI, 0.63-1.55], respectively), with probability of benefit of 56.4% and 50.7% in the ALVEOLI and ART studies, respectively. These effects were not modified by Pao2 to Fio2 ratio, driving pressure, or the severity of illness for the cohorts. INTERPRETATION: We found evidence of differential response to PEEP strategies across two ARDS subphenotypes, suggesting possible harm with a higher PEEP strategy in one subphenotype. These observations may assist with predictive enrichment in future clinical trials.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Siuba MT, Bulgarelli L, Duggal A, et al. Differential Effect of Positive End-Expiratory Pressure Strategies in Patients With ARDS: A Bayesian Analysis of Clinical Subphenotypes. Chest. 2024. PMID: 38768777. doi:10.1016/j.chest.2024.04.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。